#Spatial Omics Market Share

[healthcare-updates-with-sns]

Spatial Omics Market: Future Trends and Market Potential 2024-2032

The Spatial Omics Market was valued at USD 355.8 million in 2022 and is projected to reach USD 847.6 million by 2030, growing at a CAGR of 11.5% during the forecast period 2023–2030. This impressive growth trajectory highlights the increasing adoption of spatial omics technologies in biomedical research and clinical diagnostics, particularly in fields such as oncology, neuroscience, and immunology.

Market Overview Spatial omics technologies combine advanced imaging and molecular profiling tools to map biological molecules within their spatial context in tissues. These techniques are becoming increasingly crucial in understanding complex disease mechanisms at a cellular level, aiding in the development of precision medicine and targeted therapies. The integration of spatial transcriptomics, spatial proteomics, and metabolomics is reshaping the way researchers analyze tissue architecture and cellular heterogeneity.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/4257

Regional Analysis

North America currently dominates the spatial omics market due to robust R&D infrastructure, rising healthcare investments, and strong presence of biotech companies and research institutes.

Europe follows closely, supported by increased government funding for genomics and healthcare innovation.

Asia-Pacific is expected to witness the fastest growth, fueled by expanding healthcare systems, growing genomic research interest, and collaborations across academic and commercial sectors.

Latin America and Middle East & Africa are emerging markets showing promise due to rising diagnostic needs and improving healthcare access.

Market Segmentation

By Technology

Spatial Transcriptomics

Spatial Proteomics

Spatial Metabolomics

Multiplexed Ion Beam Imaging

By Product

Instruments

Consumables

Software

By Application

Oncology

Neurology

Immunology

Drug Discovery

Others

By End-User

Academic & Research Institutions

Pharmaceutical & Biotechnology Companies

Contract Research Organizations

KEY PLAYERS

The major key players are 10x Genomics, Dovetail Genomics (Cantata Bio.), S2 Genomics, Inc., NanoString Technologies, Inc., Seven Bridges Genomics, PerkinElmer, Inc., Bio-Techne, Danaher Corporation, Ionpath, Inc., Millennium Science Pty Ltd., and other key players

Key Highlights

Increasing prevalence of cancer and neurological disorders is fueling demand for spatial omics in clinical and translational research.

Technological advancements in imaging and sequencing platforms are enhancing resolution and scalability.

Growing collaborations between academic institutions and biotech firms are accelerating innovation.

Rising demand for personalized medicine and biomarker discovery is expanding the application of spatial omics.

Emergence of AI-driven analytical tools is streamlining data interpretation and boosting efficiency.

Future Scope The future of the spatial omics market lies in the seamless integration of multi-omics data, artificial intelligence, and cloud-based bioinformatics platforms. As spatial technologies evolve to provide higher resolution, throughput, and automation, their adoption in clinical diagnostics is expected to rise significantly. Further, expanding their utility in areas such as regenerative medicine, infectious disease research, and tissue engineering will open new avenues for market growth.

Conclusion The spatial omics market is entering a transformative phase marked by rapid technological advancements and increasing clinical relevance. With its potential to revolutionize disease diagnosis and drug development, spatial omics is emerging as a cornerstone of next-generation biomedical research. Strategic investments and cross-disciplinary collaboration will be key in unlocking its full potential across industries and regions.

Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)

Other Related Reports:

Cell Viability Assay Market

Medical Power Supply Market

Post Traumatic Stress Disorder Treatment Market

MRI Guided Neurosurgical Ablation Market

[ilmemcmi]

Spatial Omics Market Increasing Adoption of Spatial Omics in Drug Discovery and Diagnostics

Spatial omics refers to technologies that help localize gene expression and other molecular information in cells and tissues at subcellular resolution to analyze biological systems. Spatial omics allows simultaneous mapping of multiple targets in intact biological tissues to understand complex biological processes and disease pathogenesis. The technology helps obtain genomic, transcriptomic and proteomic details from specific cell types or structures within tissues. This provides better insights compared to conventional bulk-omics techniques that generate averaged measurements from biological samples containing mixed cell populations. With its ability to generate molecular spatial information while preserving tissue architecture, spatial omics is finding rising application in drug discovery, diagnostics and clinical research. Global spatial omics market is estimated to be valued at USD 315.5 Mn in 2024 and is expected to exhibit a CAGR of 9.4% during the forecast period (2024-2031).

Growing use of spatial omics techniques like spatial transcriptomics, mass spectrometry imaging and others in academic and pharmaceutical research is a key factor driving market growth. Spatial Omics Market Growth is being widely adopted by pharmaceutical companies for target identification and validation, biomarker discovery, toxicity prediction and drug efficacy evaluation during preclinical development. It is also finding increasing use in clinical applications like cancer diagnostics, immuno-oncology and neuroscience research. Spatial information helps gain a better understanding of tissue heterogeneity, cellular interactions and biomarker correlations, fueling demand for spatial omics technologies. Key Takeaways Key players operating in the spatial omics market are Gilson Company, Inc., Russell Finex Ltd., Retsch GmbH, Lao Soung Machinery Co. Ltd., Endecotts Ltd., Bionics Scientific Technologies Ltd., and Thermo Fischer Scientific, Advantech Manufacturing, Dual Manufacturing Co., Inc., and GKM Siebtechnik GmbH. Key opportunities in the spatial omics market include development of spatial omics assays and kits specific to various disease areas. This will help facilitate broader adoption of the technology across diagnostic and clinical settings. Growing investments by pharmaceutical and biotech companies in spatial biology startups is another opportunity area. Globally, North America currently dominates the spatial omics market owing to significant research funding and presence of major market players. However, Asia Pacific is anticipated to emerge as the fastest growing regional market over the forecast period driven by increasing R&D spending, biotech investments and focus on precision medicine in countries like China, India and Japan. Key players are also expanding their geographical presence across emerging markets through partnerships and new facilities. Market Drivers and Restrain The key driver for the spatial omics market is increasing focus on precision medicine. Spatial omics techniques help gain molecular insights from individual cells and regions within tissues to better understand disease pathogenesis, predict treatment response and develop targeted therapies. This supports the underlying goal of precision medicine to provide personalized healthcare based on individual patient profiles. Another major driver is rising funding for spatial biology research from government and private organizations worldwide as spatial omics holds potential to accelerate drug discovery processes. The high costs of instruments and software tools required for spatial omics experiments act as a key restraint. Spatial profiling techniques currently generate large datasets requiring costly infrastructure for data analysis, storage and sharing. Limited availability of trained professionals with expertise in spatial analysis also poses a challenge. Standardization issues associated with sample preparation, data acquisition and software tools can hamper wider adoption of spatial omics methods. However, technology advancements are expected to progressively address these restraints over the coming years.

Segment Analysis

Spatial omics sub-segment dominates the market currently. Spatial omics techniques help analyze the expression of genes and proteins at a spatial level within a tissue sample. These techniques can capture molecular information from a whole tissue slice or a tissue section in its native spatial context, enabling the visualization and mapping of molecular landscapes with cellular resolution. Advances in spatial omics techniques like multiplexed ion beam imaging (MIBI), multiplexed error-robust fluorescence in situ hybridization (MERFISH), and spatial transcriptomics are driving the growth of this sub-segment. Global Analysis

North America is expected to be the fastest growing as well as the dominating regional market during the forecast period. The presence of leading spatial omics players and availability of research funding for spatial analysis from government as well as private organizations are driving the growth of the market in this region. Asia Pacific is also expected to witness high growth rate owing to increasing research activities in countries like China and India. Research institutions and pharmaceutical companies in Asia Pacific are widely adopting spatial omics techniques for applications like biomarker discovery and drug development.

Gets More Insights on, Spatial Omics Market

About Author:

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)

[industrynewsupdates]

Global Europe, Cis & Africa Spatial Transcriptomics Market: Insights and Market Forecast

The Europe, CIS & Africa spatial transcriptomics market was valued at approximately USD 93.9 million in 2023 and is expected to experience robust growth, with a projected compound annual growth rate (CAGR) of 15.57% from 2024 to 2030. Several key factors are contributing to this growth, including the increasing recognition of spatial omics analysis in cancer research, the introduction of fourth-generation sequencing technologies (such as in-situ sequencing), and a surge in funding and collaborative initiatives aimed at advancing spatial biology research.

A primary driver behind the market expansion is the rising prevalence of cancer. As cancer rates continue to climb, there is an increasing demand for more effective approaches to biomarker discovery, early detection, and precise diagnostics. These advancements are critical for better disease management and more targeted treatment options. Spatial omics analysis, particularly in the field of oncology, has shown considerable promise in addressing these needs. It offers a more nuanced understanding of tumor heterogeneity, supports the identification of potential biomarkers, and helps inform personalized treatment strategies that can be tailored to individual patients.

One of the major advantages of spatial omics technologies is their ability to map the spatial distribution of various cell types within a tumor. This feature is vital for studying the heterogeneity of tumors, which can significantly affect treatment outcomes. A relevant example of this is a study published in Nature in May 2024, where researchers employed both spatial and single-cell transcriptomics to explore the molecular interactions and tumor heterogeneity in colorectal cancer (CRC). By using these advanced techniques, the researchers were able to gain deeper insights into the underlying mechanisms driving CRC progression, showcasing the potential of spatial transcriptomics in improving our understanding of complex diseases like cancer.

Gather more insights about the market drivers, restrains and growth of the Europe, Cis & Africa Spatial Transcriptomics Market

Country Insights

Europe led the spatial transcriptomics market in 2023, commanding a dominant share of 94.57%. This dominance can be attributed to the region's well-established biotechnology research and development (R&D) sector, its growing emphasis on spatial biology, and the presence of leading industry players. Additionally, substantial investments and funding from both public and private entities have significantly contributed to advancing spatial transcriptomics research and facilitating the commercialization of spatial omics products, further driving market growth.

United Kingdom (UK):

The spatial transcriptomics market in the UK is anticipated to experience significant growth in the coming years. This is largely due to the continuous technological advancements in spatial biology, which are increasingly being applied across various fields such as oncology, neurology, and personalized medicine. A key example of the UK's role in fostering innovation is the 12th Annual Single Cell & Spatial Analysis UK Congress, part of Next Gen Omics 2024, scheduled for October 23-25, 2024, in London. This prominent event will bring together leading experts from around the world to discuss the latest developments, cutting-edge technologies, and future prospects of spatial biology, underscoring the UK's position as a hub for research and innovation in the field.

Germany:

Germany's spatial transcriptomics market is experiencing significant growth, particularly within the broader multi-omics field. The country benefits from active engagement by renowned academic institutions, leading biotechnology and pharmaceutical companies, and substantial government-backed research funding. For example, in early 2024, the European Molecular Biology Laboratory (EMBL) hosted a series of events and training courses, focusing on integrating and analyzing multiomics data, further enhancing the country's position in spatial transcriptomics and related fields.

France:

In France, the spatial transcriptomics market is also set to witness strong growth, driven by the increasing adoption of advanced genomic technologies and their expanding applications across diverse fields such as cancer research, drug discovery, and translational research. Moreover, the French government’s continued investment in genomic research initiatives is providing a solid foundation for the market’s development, fostering both innovation and collaboration in the space.

Commonwealth of Independent States (CIS) Market Trends

The CIS region, which includes countries such as Russia, Ukraine, Belarus, and Kazakhstan, is expected to see growth in the spatial transcriptomics market. This growth is largely fueled by an increased adoption of advanced genomics and transcriptomics technologies, a growing focus on spatial biology research, and rising demand for more detailed insights into cellular function and organization. These CIS countries are home to several well-established research institutions and academic centers with deep expertise in molecular biology and biotechnology, providing a strong foundation for growth in spatial transcriptomics research and applications.

Africa Spatial Transcriptomics Market Trends

South Africa is expected to experience significant growth in the spatial transcriptomics market, driven by an increased demand for improved diagnostic tools that support disease prevention and treatment. The country’s growing healthcare sector, combined with ongoing advancements in genomic technologies, creates a promising landscape for the adoption of spatial transcriptomics.

In contrast, the Nigerian market for spatial transcriptomics remains in its early stages. While there is potential for growth, the market faces challenges due to the high costs associated with specialized equipment and reagents. Additionally, the need for skilled labor to operate these advanced technologies represents another potential barrier to rapid market development. As such, significant investment in infrastructure, training, and research capacity will be necessary to accelerate market growth in Nigeria and other parts of West Africa.

Browse through Grand View Research's Biotechnology Industry Research Reports.

• The global exosomes market size was estimated at USD 177.4 million in 2024 and is anticipated to grow at a CAGR of 28.73% from 2025 to 2030. 

• The global cell culture media storage containers market size was estimated at USD 2.11 billion in 2024 and is projected to witness a CAGR of 12.55% from 2025 to 2030. 

Key Europe, CIS & Africa Spatial Transcriptomics Company Insights

Several key players in the spatial transcriptomics market are actively pursuing strategies to strengthen their market presence and expand the reach of their products and services. These strategies primarily include expansion activities and strategic partnerships aimed at advancing research, increasing the commercialization of spatial omics products, and enhancing collaborations between academia and industry. Through these initiatives, companies are not only boosting their market footprint but are also contributing to the broader advancement of spatial biology and transcriptomics technologies.

Key Europe, CIS & Africa Spatial Transcriptomics Companies:

• Illumina, Inc.

• Bruker

• 10X Genomics

• EdenRoc Sciences (Cantata Bio, LLC)

• Shimadzu Corporation

• Waters Corporation

• Bio-Techne

• Vizgen Inc.

• Spatial Genomics

• Akoya Biosciences, Inc

Order a free sample PDF of the Europe, Cis & Africa Spatial Transcriptomics Market Intelligence Study, published by Grand View Research.

[bommagoni]

Spatial OMICS Market Size, Share, Trends, Forecast Report 2030

[desaletushki]

Omics-Based Clinical Trials Market Size Is Anticipated To Reach $49.5 Billion By 2030

The global omics-based clinical trials market size is anticipated to reach USD 49.5 billion by 2030, according to the new report of Grand View Research, Inc. The market is expected to expand at a CAGR of 7.4% from 2022 to 2030. Omics has turned out to be the most advanced approach in molecular research. It includes all the field of biological sciences that ends with the suffix - omics. Various disciplines can be classified as omics such as proteomics, genomics, transcriptomics, and metabolomics. The outbreak of coronavirus accelerated the adoption of new approaches, models, and technology in clinical trials, this has positively impacted market growth.

The outbreak of COVID-19 has caused havoc and has disrupted almost every sector of industry.

Initially, the outbreak has negatively impacted the ecosystem of clinical trials and affected many ongoing studies for numerous indications. However, in the second half of 2020, researchers started developing innovative therapeutics and vaccines against COVID-19, which has supported the market recovery and growth, and continuance of business by CROs. There has been an increase in the clinical trials activity with oncology trials attaining historically high levels. The extensive research for understanding the COVID-19 infection has turned the attention to the application of omics-based studies.

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/omics-based-clinical-trials-market-report

For instance, in June 2021, a group of researchers at University Hospital Tuebingen initiated a clinical trial on comparative genetic and immune response analysis of different COVID-19 vaccine candidates using a multi-omics approach. The growing application of spatial OMICS, for the identification of biomarkers, is a major factor boosting the growth of the market. To study the efficacy and toxicity of the drug, spatial OMICS play a major role and have simplified drug discovery and development. Biomarker identification along with the clinical application is widely used in drug development and discovery. Biomarkers are used to identify the pathway of the diseases and the progression and help to understand the cause.

The rising prevalence of chronic diseases such as cancer and cardiac disorders and the increasing demand for omics-based clinical trials in developing countries are boosting the market’s growth. Cancer is one of the leading causes of death in the United States. In 2018 alone, there were an estimated 1,735,350 new diagnoses and 609,640 cancer-related deaths. Single-cell multi-OMIC analysis is a novel tool that is opening doors in cancer drug development and further advance the current treatment options. The market is also driven by a rising number of biologics, demand for advanced technologies, and the need for personalized medicines and orphan drugs. Additionally, growing biotechnology and the pharmaceutical industry have propelled the demand for non-invasive instruments, full applications for single-cell multi-omics technology, and conventional labs are bolstering future market growth.

Omics-Based Clinical Trials Market Highlights

By phase type, phase II segment held the largest market share in 2021 with a share of 37.8% due to the major number of phase II omics-based ongoing clinical trials

Based on the study design, interventional studies had the highest market share in 2021 since, among the three types of studies, interventional studies accounted for a larger number of clinical trials, especially in oncology

The oncology segment dominated the indication segment in 2021 owing to the rising research attention in the field and increasing demand for omics-based clinical trials for early detection and prevention of the disease

North America is expected to maintain its lead in the market over the forecast period owing to technological advancements, rising R&D, and the presence of major pharmaceutical and biotechnology players in the region

Key Companies & Market Share Insights

The market for omics-based clinical trials is highly competitive in nature due to the presence of a substantial number of developed as well as medium to small-sized organizations Several market participants are privately held or are a part of private equity firms’ portfolios. For instance, In March 2018, Danaher Corporation acquired Integrated DNA Technologies. This acquisition aimed at expanding Danaher’s presence in the highly attractive genomics market. Another company is Rebus Biosystems Inc., a U.S.-based life science technology company in December 2021, announced that it has acquired the assay assets and IP of EEL Transcriptomics AB, a company that is privately held focused on high-plex spatial transcriptomics based on single-cell resolution. Some of the prominent players in the omics-based clinical trials market include: Parexel International Corporation, Pharmaceutical Product Development (PPD), Charles River Laboratory, ICON plc, SGS SA, Eli Lilly and Company, Pfizer Inc., Covance Inc., Novo Nordisk, Rebus Bio

Request Free Sample Report: https://www.grandviewresearch.com/industry-analysis/omics-based-clinical-trials-market-report

[wemarketresearchreport]

Spatial Genomics and Transcriptomics Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2030

Spatial Genomics and Transcriptomics Market size was $163.8 million in 2020, and is expected to grow at a value of more than $470.55 million by 2030, registering a CAGR (Compound annual growth rate) of over 11% from 2022 to 2030.

The discovery of spatial reorganisation of the genome in various diseases is expected to increase the use of spatial genome placement patterns in disease diagnosis. Several modest and large-scale retrospective investigations have been conducted to demonstrate the feasibility of using genomic location as a diagnostic tool. This is expected to drive the use of spatial genomics and transcriptomics technologies, resulting in an increase in organic revenue flow in the space. Key players are working to provide technologically enhanced solutions and platforms to better support the research and clinical domain while also increasing their revenue share in various end-use scenarios.

Request a sample copy of Spatial Genomics and Transcriptomics Market

The growth of the spatial genomics and transcriptomics market is fueled by an increase in adoption of these technologies for various applications such as stem cell and cancer research, tissue-specific gene expression studies, embryogenesis and in-vitro fertilisation, and characterization of non-coding RNAs, among others. Furthermore, the rise in the prevalence of genetic illnesses, the use of spatial genomics and transcriptomics in the determination of disease and treatment indicators, as well as a growing preference for tailored treatments, all contribute to the market's growth. During the projection period, however, a scarcity of experienced specialists, as well as ethical and regulatory limits connected with the use of spatial genomics and transcriptome technologies, are projected to stymie market expansion. On the other hand, there has been a spike in spatial genomics innovation.

Global Spatial Genomics and Transcriptomics Market: Segmentations

By Key Players

Akoya Biosciences, Inc.

BioSpyder Technologies Inc.

Bio-Techne Corporation (Advanced Cell Diagnostics, Inc.)

Dovetail Genomics, LLC

Fluidigm Corporation

Genomic Vision SA, Illumina, Inc.

Lunaphore Technologies SA

Nanostring Technologies, Inc.

Natera Inc.

PerkinElmer Inc. (Horizon Discovery Group Plc.)

Rarecyte, Inc.

Rebus Biosystems, LLC

Resolve Biosciences

S2 Genomic

Seven Bridges Genomics

Singular Genomics System, Inc.

Tecan Group Ltd. (Nugen Technologies, Inc.)

Ultivue, Inc.

Veranome Biosystems LLC

Vizgen Corporation

By workflow, the market is fragmented into spatial imaging, spatial analysis, and spatial sequencing. On the basis of product type, the industry is classified into-

• Instruments

o By mode (automated, semi-automated, and manual)

o By type (sequencing platforms, IHC, microscopy, flow cytometry, mass cytometry, and others)

• Consumables

• Software

o Bioinformatics tools

o Imaging tools

o Storage and management databases

Spatial Genomics and Transcriptomics Market: Competitive Landscape

Major market companies are concentrating their efforts on expanding their spatial transcriptomics and genomics impressions by entering key organisations and collaborating with other players. In addition, the companies are making strategic moves to expand their client base around the world. For example, Dovetail Genomics announced the global availability of its Dovetail HiChIP and Micro-C Kits in February 2020, and ReadCoor, Inc. unveiled its first product offering that includes the RC2 equipment and multi-omic spatial sequencing studies. The gadget activates the organization's Fluorescent in Situ Sequencing (FISSEQ) technology.

Dovetail Micro-C units provide a better goal of chromatin interactions at the mononucleosome level, whereas HiChIP technology combines Micro-C and ChIP-seq into a single work process, allowing protein-guided chromatin architectural modifications to be tested.

Purchase Global Spatial Genomics and Transcriptomicss Market Research Report

Table Of Contents (TOC)

1. Global Spatial Genomics and Transcriptomics Market Introduction and Market Overview

2. Global Spatial Genomics and Transcriptomics Market - Executive Summary

3. Spatial Genomics and Transcriptomics Market Trends, Outlook, and Factors Analysis

4. Global Spatial Genomics and Transcriptomics Market: Estimates & Historic Trend Analysis (2018 to 2021)

5. Global Spatial Genomics and Transcriptomics Market Estimates & Forecast Trend Analysis, by Deployment

6. Global Spatial Genomics and Transcriptomics Market Estimates & Forecast Trend Analysis, by Component

7. Global Spatial Genomics and Transcriptomics Market Estimates & Forecast Trend Analysis, by Content Type

8. Global Spatial Genomics and Transcriptomics Market Estimates & Forecast Trend Analysis, by End Use

9. Global Spatial Genomics and Transcriptomics Market Analysis and Forecast, by Region

10. North America Spatial Genomics and Transcriptomics Market: Estimates & Forecast Trend Analysis\

11. Europe Spatial Genomics and Transcriptomics Market: Estimates & Forecast Trend Analysis

12. Asia Pacific Spatial Genomics and Transcriptomics Market: Estimates & Forecast Trend Analysis

13. Middle East & Africa Spatial Genomics and Transcriptomics Market: Estimates & Forecast Trend Analysis

14. Latin America Spatial Genomics and Transcriptomics Market: Estimates & Forecast Trend Analysis

15. Competitive Landscape

16. Company Profiles

17. Assumptions and Research Methodology

18. Conclusions and Recommendations

 Key Questions answered in the India Spatial Genomics and Transcriptomics Market Report are:

1.     Which product segment grabbed the largest share in the India Spatial Genomics and Transcriptomics market?

2.     How is the competitive scenario of the India Spatial Genomics and Transcriptomics market?

3.     Which are the key factors aiding the India Spatial Genomics and Transcriptomics market growth?

4.     Which region holds the maximum share in the India Spatial Genomics and Transcriptomics market?

5.     What will be the CAGR of the India Spatial Genomics and Transcriptomics market during the forecast period?

6.     Which application segment emerged as the leading segment in the India Spatial Genomics and Transcriptomics market?

7.     Which are the prominent players in the India Spatial Genomics and Transcriptomics market?

8.     What key trends are likely to emerge in the India Spatial Genomics and Transcriptomics market in the coming years?

9.     What will be the India Spatial Genomics and Transcriptomics market size by 2028?

10.                        Which company held the largest share in the India Spatial Genomics and Transcriptomics market?

About We Market Research

WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.

Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. WE MARKET RESEARCH is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients.

Contact Us:

We Market Research

Phone: +1(929)-450-2887

Email: sales@wemarketresearch.com

Web:

https://wemarketresearch.com

[myoliver123stuff]

Spatial OMICS Market is estimated to reach at $1584.22 Mnby 2030

The global Spatial OMICS market size is expected to be worth around US$ 584.22 Mn by 2030, according to a new report by Trends Market Research.

The global Spatial OMICS market size was valued at US$ 305.81 Mn in 2020 and is anticipated to grow at a CAGR of 15.05% during forecast period 2021 to 2030.

Growth Factors

Startups and well-established players continued their product development and launched novel solutions, democratized their offerings beyond innovators, and engaged in mergers & acquisitions. The spatial OMICS field originated from hyperplexed imaging; however, key players have shifted toward the development of spatial transcriptomics solutions and products.

Rapid advances in the sequencing of tissues, genes, and single cells have resulted in the emergence of spatial genomic sequencing. Spatial OMICS techniques offer quantitative gene expression data and visualization of DNA and RNA mapping within tissue sections. The development of novel technologies for spatial OMICS is anticipated to create lucrative opportunities for the fields of translational research as well as diagnostics.

The spatial genomics technology segment is expected to expand at the fastest CAGR throughout the forecast period owing to a rise in the launch of novel platforms. The integration of high-throughput solutions in transcriptomics, genomics, and proteomics studies has enabled determining the link between disease occurrence and genome position.

Report Highlights

The spatial transcriptomics segment dominated the market with a share of 73.56% in 2020. Continuous advancements in sequencing technologies have accelerated the transcriptomic study of single cells. For the comprehensive study of multicellular organisms, efforts are being taken to design novel solutions for high-throughput genomic analysis while maintaining the spatial information of the sample/tissue under observation or subcellular localization of analyzed DNA/RNA.

Download Research Sample with Industry Insights @ https://www.trendsmarketresearch.com/report/sample/13641

The development of various in situ methods enhances the capabilities to explore spatial information in biological investigation. These methods have led to the convergence of function-oriented fields of biochemistry and molecular genetics with structure-focused fields such as histology and embryology, thereby enabling spatially resolved molecular investigation of biological processes.

The consumables segment accounted for the largest share of 63.01% in 2020 owing to the high utilization rate and launch of novel products. For instance, in March 2021, Bruker launched new consumables for the chemical cross-linking of proteins (XL-MS). The new PhoX cross-linker facilitates the purification of protein from XL-MS reaction complex mixtures. Moreover, the company plans to launch three cleavable cross-linkers for cleaving the cross-linkers generated in MS experiments.

The launch of new instruments is directly associated with the development of the consumables. Therefore, this drives the instruments as well as the consumables segment. In December 2020, NanoString announced the development of spatial molecular imager (SMI). It is a next-generation spatial OMICS platform designed for multiplexed protein and RNA analysis for single cells in FFPE tissue samples. The platform is expected to be launched by 2022.

The instrumental analysis segment dominated the market with a revenue share of 57.69% in 2020. The growth of the segment can be primarily attributed to substantial advancements being performed in instruments such as microscopy and mass spectrometry. Mass spectrometry is one of the most promising tools that is used for quantifying nucleic acid and proteins.

It has several advantages such as high resolution, high speed, and high-throughput operations for profiling of protein, which are later used for analyzing complex biological samples. This facilitates novel applications such as new drug development, biomarker discovery, and diagnostics.

The formalin fixation and paraffin-embedding (FFPE) segment held the largest share of 67.26% in 2020. FFPE is considered a standard sample type that is most used for the preservation of human tissue for clinical diagnosis, and hence it holds a major share in the global market. This technique is considered the best in researching tissue morphology for clinical histopathology and diagnostic purposes.

In addition, FFPE specimens are found in abundance in clinical tissue banks, which contributes to the segment growth. However, they are incompatible with single-cell level transcriptome sequencing owing to RNA degradation and RNA damage during storage and extraction. Hence, researchers are focusing on new approaches for increasing the application of FFPE in spatial transcriptomic studies.

The academic and translational research institutes segment dominated the market with a revenue share of 99.60% in 2020. An increase in the adoption of spatial OMICS to translate real-time tissue responses to an external agent increases the technology’s adoption in translational research. Translational studies in the field of genomics help researchers and healthcare practitioners analyze the behavior of human tissues and cells from different individuals in different environments.

This vital information may lead to the evolution of new and better ways to prevent diseases. For instance, single-cell transcriptomics is found to be useful for neuroscientists to understand cell types forming the brain. These methods help understand the spatial architecture of nervous tissues and evaluate the brain’s function. However, this further requires linking molecular cell types to physiological, morphological, and behavioral factors.

Direct Purchase this Market Research Report Now @ https://www.trendsmarketresearch.com/checkout/13641/Single

North America accounted for the largest share of 54.80% in 2020. This can be attributed to the increasing prevalence of cancer, the growing demand for personalized medicine, well-developed healthcare facilities, and the availability of novel diagnostic techniques. The growing morbidity and mortality rates due to cancer and other metabolic, autoimmune, and inflammatory disorders have led to an increase in the need for developing novel therapies, thereby driving the market in this region.

In addition, companies operating in North America are launching new initiatives and programs for discovering and increasing translational applications, which is further contributing to the market growth. For instance, in March 2021, NanoString Technologies, Inc. launched the Technology Access Program (TAP) through which the company will analyze tissue samples of patients using the Spatial Molecular Imager platform and GeoMx Digital Spatial Profiler. Hence, such initiatives help in expanding spatial biology applications in the region.

Key Players

10x Genomics

Dovetail Genomics

S2 Genomics, Inc.

NanoString Technologies, Inc.

Seven Bridges Genomics

PerkinElmer, Inc.

Bio-Techne

Danaher Corporation

IonPath, Inc.

Millennium Science Pty Ltd.

Akoya Biosciences, Inc.

Fluidigm Corporation

Diagenode Diagnostics

Biognosys AG

Rebus Biosystems

Ultivue, Inc.

Vizgen Corp.

BioSpyder Technologies

Bruker

Brooks Automation, Inc.

Market Segmentation

Technology Outlook

Spatial Transcriptomics

Sequencing-based Methods

Laser capture microdissection (LCM), by tissue type

FFPE tissue samples

Others

Transcriptome in-vivo analysis (TIVA)

In situ sequencing

Microtomy sequencing

Microscopy-based RNA Imaging Techniques, by methodsSingle Molecule RNA Fluorescence In-Situ Hybridization (smFISH) Padlock Probes/ Rolling Circle Amplification Branched DNA probes

Spatial GenomicsFISH Microscopy-based Live DNA Imaging Genome Perturbation Tools Massively-parallel Sequencing Biochemical Techniques Others

Spatial Proteomics Imaging TechniquesMicroscopy Multiplexed Ion Beam Imaging Mass Spectrometry Immunofluorescence Techniques Centrifugation Techniques Others

Product Outlook Instruments By ModeAutomated Semi-automated Manual By TypeSequencing Platforms IHC Microscopy Flow Cytometry Mass Spectrometry Others Consumables SoftwareBioinformatics tools Imaging tools Storage and management databases

Workflow OutlookSample Preparation Instrumental Analysis Data Analysis

Sample Type OutlookFFPE Fresh Frozen

End-use Outlook (Revenue, USD Million, 2017 - 2028)Academic & Translational Research Institutes Pharmaceutical and Biotechnology Companies

The Spatial OMICS market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

Get Up to 10 % Discount on single User @ https://www.trendsmarketresearch.com/report/discount/13641

The report provides size (in terms of volume and value) of Spatial OMICS market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global Spatial OMICS market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Spatial OMICS market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted Spatial OMICS market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.